So what are your projections for peak annual sales of Uplyso for PLX given its 40% share of revenue? $100M? $200M? North or south of those figures?
Was there anything in particular during the CC you heard that caused you to add to your position? What gives you the confidence that the FDA will ultimately approve Uplyso and in a timely manner? The ultimate approval of Uplyso is so critical for PLX because this is their first drug and this will either validate their entire pipeline or call it entirely into question. If one can gain confidence around the former then the stock probably looks very cheap now at ~$600M market cap. But there is a lot of risk as I don't know that one can entirely rule out the latter just yet.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.